| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 45,091 | 45,814 | 45,095 | 46,540 | | Cost of Revenue | 2,626 | 2,500 | 2,495 | 3,848 | | | Gross Profit |
-
| 43,314 | 42,600 | 42,692 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,604 | 31,920 | 31,246 | 29,693 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 13,358 | 9,436 | 9,421 | 13,806 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,958 | 1,933 | (807) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,497) | 1,958 | 1,933 | (807) | | Interest Expense | 1,609 | 1,585 | 1,563 | 1,634 | | Income Before Tax | (3,106) | 373 | 370 | (2,441) | | Income Tax Expense | (1,618) | (401) | (280) | (738) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,488) | 774 | 650 | (1,703) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,488) | 774 | 650 | (1,703) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,488) | $774 | $650 | ($1,703) |
|
0.11% Nasdaq 
0.01%
Income Statement
